231 related articles for article (PubMed ID: 35805464)
21. Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden.
Zhou Z; Ong KL; Whelton SP; Allison MA; Curtis AJ; Blaha MJ; Breslin M; Tonkin A; Magnussen CG; Budoff M; Nelson MR
Mayo Clin Proc; 2022 Oct; 97(10):1883-1893. PubMed ID: 35760597
[TBL] [Abstract][Full Text] [Related]
22. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
23. Sleep duration and the risk of future lipid profile abnormalities in middle-aged men: the Kansai Healthcare Study.
Kinuhata S; Hayashi T; Sato KK; Uehara S; Oue K; Endo G; Kambe H; Fukuda K
Sleep Med; 2014 Nov; 15(11):1379-85. PubMed ID: 25220668
[TBL] [Abstract][Full Text] [Related]
24. Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study.
Stergiou GS; Ntineri A; Menti A; Kalpourtzi N; Vlachopoulos C; Liberopoulos EN; Rallidis L; Richter D; Gavana M; Vantarakis A; Chlouverakis G; Hajichristodoulou C; Trypsianis G; Voulgari PV; Alamanos Y; Karakosta A; Touloumi G
Hellenic J Cardiol; 2023; 69():1-8. PubMed ID: 36243397
[TBL] [Abstract][Full Text] [Related]
25. Triglyceride is independently correlated with insulin resistance and islet beta cell function: a study in population with different glucose and lipid metabolism states.
Ma M; Liu H; Yu J; He S; Li P; Ma C; Zhang H; Xu L; Ping F; Li W; Sun Q; Li Y
Lipids Health Dis; 2020 Jun; 19(1):121. PubMed ID: 32487177
[TBL] [Abstract][Full Text] [Related]
26. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
[TBL] [Abstract][Full Text] [Related]
27. Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study.
Saari K; Koponen H; Laitinen J; Jokelainen J; Lauren L; Isohanni M; Lindeman S
J Clin Psychiatry; 2004 Apr; 65(4):547-50. PubMed ID: 15119919
[TBL] [Abstract][Full Text] [Related]
28. Postprandial hyperlipidemia as a potential residual risk factor.
Nakamura K; Miyoshi T; Yunoki K; Ito H
J Cardiol; 2016 Apr; 67(4):335-9. PubMed ID: 26744235
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
[TBL] [Abstract][Full Text] [Related]
30. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
31. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
[TBL] [Abstract][Full Text] [Related]
32. Association between chronic kidney disease and new-onset dyslipidemia: The Japan Specific Health Checkups (J-SHC) study.
Kosugi T; Eriguchi M; Yoshida H; Tasaki H; Fukata F; Nishimoto M; Matsui M; Samejima KI; Iseki K; Fujimoto S; Konta T; Moriyama T; Yamagata K; Narita I; Kasahara M; Shibagaki Y; Kondo M; Asahi K; Watanabe T; Tsuruya K;
Atherosclerosis; 2021 Sep; 332():24-32. PubMed ID: 34375910
[TBL] [Abstract][Full Text] [Related]
33. Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia.
Bays HE; Chapman RH; Fox KM; Grandy S;
Curr Med Res Opin; 2008 Apr; 24(4):1179-86. PubMed ID: 18346311
[TBL] [Abstract][Full Text] [Related]
34. Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women's Health Across the Nation (SWAN).
Chang PY; Gold EB; Cauley JA; Johnson WO; Karvonen-Gutierrez C; Jackson EA; Ruppert KM; Lee JS
J Clin Endocrinol Metab; 2016 Sep; 101(9):3297-305. PubMed ID: 27294327
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population.
Kutkiene S; Petrulioniene Z; Laucevicius A; Matuzeviciene G; Kasiulevicius V; Petrulionyte E; Staigyte J; Saulyte A; Gargalskaite U; Skiauteryte E; Kovaite M; Rinkuniene E
Lipids Health Dis; 2018 Sep; 17(1):208. PubMed ID: 30185180
[TBL] [Abstract][Full Text] [Related]
36. Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan.
Chang YC; Lin CJ; Yeh TL; Tsai MC; Hsu LY; Chien KL; Hsu HY
Lipids Health Dis; 2021 Oct; 20(1):133. PubMed ID: 34629064
[TBL] [Abstract][Full Text] [Related]
37. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
Pennell P; Leclercq B; Delahunty MI; Walters BA
Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
[TBL] [Abstract][Full Text] [Related]
38. Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200-499 mg/dL) Are Significant Predictors of Hospitalization for New-Onset Kidney Disease: A Real-World Analysis of High-Risk Statin-Treated Patients.
Toth PP; Philip S; Hull M; Granowitz C
Cardiorenal Med; 2019; 9(6):400-407. PubMed ID: 31450229
[TBL] [Abstract][Full Text] [Related]
39. Serum Lipid Profiles and Cholesterol-Lowering Medication Use in Relation to Subsequent Risk of Colorectal Cancer in the UK Biobank Cohort.
Yuan F; Wen W; Jia G; Long J; Shu XO; Zheng W
Cancer Epidemiol Biomarkers Prev; 2023 Apr; 32(4):524-530. PubMed ID: 36780218
[TBL] [Abstract][Full Text] [Related]
40. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.
Guan Y; Hou X; Tian P; Ren L; Tang Y; Song A; Zhao J; Gao L; Song G
Front Endocrinol (Lausanne); 2021; 12():646185. PubMed ID: 33967959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
